FDA clears Boston Scientific endoscopic catheter

Justine Varieur Cadet | | Health Imaging | Screening
Boston Scientific has received 510(k) clearance from the FDA to market its SpyScope Access and Delivery catheter for diagnostic and therapeutic applications during endoscopic procedures of the pancreatico-biliary system.

The SpyScope catheter is used in conjunction with the SpyGlass Direct Visualization system, according to the Natick, Mass.-based company.

Previously available for use in the bile and hepatic ducts, the SpyGlass system can now be used to guide visualization and accessory devices throughout the pancreatico-biliary system, allow physicians to diagnose and treat pancreatic cancer or pre-cancerous tissues, Boston Scientific said.

Justine Varieur Cadet

Related Content

AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.